We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$77.2B
AUM Growth
+$3.78B
Cap. Flow
+$3.39B
Cap. Flow %
4.39%
Top 10 Hldgs %
11.56%
Holding
4,729
New
599
Increased
1,385
Reduced
1,503
Closed
674

Top Buys

Rank Stock Value
1
FWONK icon
Liberty Media Series C
FWONK
+$430M
2
BABA icon
Alibaba
BABA
+$364M
3
HPQ icon
HP
HPQ
+$298M
4
PFE icon
Pfizer
PFE
+$258M
5
BKNG icon
Booking.com
BKNG
+$244M

Sector Composition

Rank Sector Weight
1 Technology 8.89%
2 Consumer Discretionary 8.28%
3 Energy 7.75%
4 Healthcare 6.77%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXGN
3776
PUT
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$241K ﹤0.01%
17,500
-700
-4% -$10.6K
ADMS
3777
DELISTED
Adamas Pharmaceuticals
ADMS
$241K ﹤0.01%
12,969
-20,415
-61% -$351K
FST
3778
DELISTED
FOREST OIL CORPORATION
FST
$241K ﹤0.01%
205,645
-420,509
-67% -$763K
MOV icon
3779
Movado Group
MOV
$812M
$240K ﹤0.01%
7,251
-255
-3% -$9.99K
PMCS
3780
DELISTED
P M C SIERRA INC
PMCS
$240K ﹤0.01%
32,135
-85,696
-73% -$627K
RALY
3781
PUT
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$240K ﹤0.01%
20,000
FMBI
3782
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$239K ﹤0.01%
+14,841
New +$249K
CEL
3783
DELISTED
Cellcom Israel, Ltd.
CEL
$238K ﹤0.01%
21,636
-11,536
-35% -$137K
AUB icon
3784
Atlantic Union Bankshares
AUB
$5.99B
$237K ﹤0.01%
+10,239
New +$247K
CMC icon
3785
Commercial Metals
CMC
$7.63B
$237K ﹤0.01%
+13,913
New +$244K
ENZ
3786
DELISTED
Enzo Biochem, Inc.
ENZ
$237K ﹤0.01%
46,096
-40,560
-47% -$216K
ENOC
3787
DELISTED
EnerNOC, Inc.
ENOC
$236K ﹤0.01%
13,918
-43,760
-76% -$818K
WD icon
3788
Walker & Dunlop
WD
$1.65B
$235K ﹤0.01%
+17,678
New +$245K
AMED
3789
PUT
DELISTED
Amedisys
AMED
$234K ﹤0.01%
+11,600
New +$224K
EXAS
3790
CALL
DELISTED
Exact Sciences
EXAS
$234K ﹤0.01%
+12,100
New +$222K
KAMN
3791
DELISTED
Kaman Corp
KAMN
$234K ﹤0.01%
+5,960
New +$244K
LIOX
3792
DELISTED
Lionbridge Technologies
LIOX
$234K ﹤0.01%
52,070
+26,863
+107% +$137K
MOBI
3793
DELISTED
Sky-mobi Limited ADS
MOBI
$234K ﹤0.01%
28,789
-128,000
-82% -$976K
SQBK
3794
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
$234K ﹤0.01%
+12,181
New +$232K
HHS icon
3795
Harte-Hanks
HHS
$233K ﹤0.01%
+3,657
New +$249K
MTRN icon
3796
Materion
MTRN
$5.01B
$233K ﹤0.01%
7,586
-17,123
-69% -$582K
AXON
3797
CALL
Axon Enterprise
AXON
$40.5B
$232K ﹤0.01%
15,000
ABUS icon
3798
Arbutus Biopharma
ABUS
$865M
$231K ﹤0.01%
+10,906
New +$178K
MIND icon
3799
MIND Technology
MIND
$50.4M
$231K ﹤0.01%
+2,087
New +$265K
QDEL icon
3800
PUT
QuidelOrtho
QDEL
$1.09B
$231K ﹤0.01%
8,600
-3,200
-27% -$76.3K

Similar funds

D.E. Shaw & Co's Q3 2014 Portfolio in Review

As of Q3 2014, D.E. Shaw & Co held 4,729 positions worth $77.2B, up 5.1% from $73.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co deployed $3.39B of net new capital in Q3 2014, opening 599 new positions and adding to 1,385 existing holdings. Its largest new stake was Liberty Media Series C: 16,804,239 shares worth $422M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Liberty Media Series A, an estimated $321M trimmed.

  • D.E. Shaw & Co's largest Q3 2014 buy was Liberty Media Series C: 16,804,239 shares worth $422M.
  • D.E. Shaw & Co added most to HP in Q3 2014, an estimated $298M increase.
  • D.E. Shaw & Co's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $321M.
  • D.E. Shaw & Co fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $602M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $77.2B portfolio in Q3 2014.
  • D.E. Shaw & Co opened 599 new positions and closed 674 in Q3 2014.
  • D.E. Shaw & Co's portfolio value rose 5.1% quarter-over-quarter to $77.2B.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.